Lilly's New Drug Shows Superior Weight Loss in Trial Against Zepbound | Retatrutide News

Eli Lilly's experimental drug outperformed Zepbound in a weight-loss trial, highlighting its potential in obesity treatment. This development is relevan...
Clinical Trials · October 13, 2026